BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Cell Care Australia Acquires Insception Lifebank in Canada
Cell Care Acquires Insception Lifebank

Cell Care Australia Acquires Insception Lifebank in Canada

October 26, 2016 By Cade Hildreth (CEO) Leave a Comment

The largest cord blood bank in Australia, Cell Care, has announced that it is acquiring the largest cord blood bank in Canada, Insception Lifebank. This acquisition is part of a larger trend occurring within the cord blood banking industry, which is the trend of maturation and consolidation.

Discover class-defining bioproduction tools.

Over the past five years, the cord blood and tissue marketplace has undergone substantial consolidation. One major event was the acquisition of the United States’ largest cord blood, Cord Blood Registry (CBR), by AMAG Pharmaceuticals for $700M in March of 2015. Previously, ViaCord had been acquired by the multinational company PerkinElmer in October 2007 for $300M. 

Human Longevity also acquired LifebankUSA from Celgene in January of 2016, AlphaCord’s acquired LifeSource Cryobank in November of 2015, and  FamilyCord acquired Southern Cord in April of 2016.

bitbio

The  merger of Cell Care and Insception Lifebank is a powerful move, because it will create one of the ten largest cord blood banks worldwide, with more than 100K cord blood and tissue units in storage. It will also promote clinical trial and R&D activity between the two companies.CellCare Insception Lifebank

Cell Care and Insception Lifebank Partner for Research and Clinical Collaboration

Insception Lifebank, Canada's Largest Cord Blood BankAs stated in the news release from Insception Lifebank, “The combined entity creates one of the world’s top 10 companies in the sector. Together, they store over 100,000 client samples and the union establishes an excellent platform for further international expansion. The coming together provides the two companies with a stronger base from which to expand current clinical trials and R&D activities globally. ”

Pluristyx

Cell Care, Australia's Largest Cord Blood BankAs highlighted in Cell Care’s coverage of the acquisition, “The transaction provides the two companies with a stronger base from which to expand current clinical trials and R&D activities globally. Cell Care is currently funding cord blood trials in areas such as cerebral palsy and type-1 diabetes. Insception Lifebank has strong alliances with internationally reputed hospitals in Canada, and the new merged entity will endeavour to extend these relationships into research collaborations similar to those developed in Australia. Led by Dr. Ian Rogers, Insception’s research in the area of induced pluripotent stem cells will be leveraged with Cell Care’s Australian partnerships.”

To learn more, view the following company releases:

Cell Care: https://www.cellcare.com.au/banking-with-cell-care/news

Insception Lifebank: http://www.insception.com/news-press-releases/cord-blood-news/alliance

iPSC-derived cardiomyocte therapy
Rate this post

Filed Under: Cord Blood, HSCs, Press Releases, Stem Cell News, Stem Cells Tagged With: acquisition, Cell Care, cord blood, Insception Lifebank

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.